Analyst Ratings February 11, 2026

Truist Lifts James Hardie Price Target to $30 After Strong Quarter and Upgraded Guidance

Analyst maintains Buy rating as results and management commentary point to improvement in siding and decking segments

By Maya Rios JHX
Truist Lifts James Hardie Price Target to $30 After Strong Quarter and Upgraded Guidance
JHX

Truist Securities raised its price objective on James Hardie Industries to $30.00 from $28.00 and kept a Buy rating after the building materials maker reported quarterly results that came in modestly above expectations and issued higher guidance for the fiscal year ending March 2026. The firm highlighted progress in decking and reduced siding volume pressure, while management signalled confidence in growing revenues and earnings in fiscal 2027 through operational levers independent of new housing or repair-and-remodel market trends.

Key Points

  • Truist raised James Hardie's price target to $30.00 from $28.00 and kept a Buy rating.
  • Quarterly results beat estimates - EPS $0.26 vs $0.22 expected; revenue $1.29B vs $1.21B expected.
  • Management forecasts growth in fiscal 2027 via synergies, cost savings, and marketing, independent of new housing or repair-and-remodel markets.

Truist Securities has increased its price target for James Hardie Industries (JHX) to $30.00 from $28.00 and reiterated a Buy rating following the company's most recent quarterly report. The new target aligns with the highest analyst estimate for the company, which has a market capitalization of $13.7 billion and was trading at $26.42 at the time the data were cited. Market valuation metrics cited with the results show a price-to-earnings ratio near 65, which the data indicate is elevated relative to an assessed fair value.

Truist characterized James Hardie's quarterly results as "modestly above" Street expectations and noted that the company raised guidance for the fiscal year ending March 2026. The brokerage emphasized specific operational improvements that underpinned the outperformance: growth in the decking business, "modestly less siding volume pressure," and some price gains within the siding segment. Those factors, Truist said, contributed to the company beating forecasts for the period.

The company reported third-quarter results for fiscal 2026 that exceeded analysts' estimates. Earnings per share came in at $0.26 versus a consensus forecast of $0.22, an 18.18% surprise. Revenue for the quarter was $1.29 billion, beating the anticipated $1.21 billion. The earnings announcement was followed by a rise in the company’s share price.

James Hardie has shown solid top-line expansion over the past year, with revenue growth of 12.59% over the last twelve months. Management also conveyed confidence in their ability to grow both the top and bottom lines in fiscal 2027 through synergies, cost savings, and marketing initiatives - and crucially, to do so independent of new housing starts or repair-and-remodel market conditions. Truist flagged this independent-growth capability as a critical element for the stock to become "a substantial group outperformer."

Financial analysts have begun to reflect the changed outlook in their models: three analysts have recently raised their earnings estimates for JHX. The stock has exhibited notable momentum year-to-date, with a total return of 17.49% as cited in the data alongside the coverage.


Summary

  • Truist bumped its price target on James Hardie to $30.00 and kept a Buy rating after quarterly results were "modestly above" expectations and guidance was increased for fiscal 2026.
  • Operational drivers cited include decking growth, reduced siding volume pressure, and price gains in siding; the company also reported stronger-than-expected EPS and revenues for the quarter.
  • Management expects to grow revenue and earnings in fiscal 2027 through synergies, cost reductions, and marketing, irrespective of the broader housing or repair-and-remodel markets.

Key points

  • Price target and rating - Truist raised JHX's target to $30.00 from $28.00 and maintained a Buy rating.
  • Quarterly beat - EPS of $0.26 versus $0.22 expected and revenue of $1.29 billion versus $1.21 billion expected.
  • Market reaction and momentum - stock up following the release and a cited year-to-date return of 17.49%.

Risks and uncertainties

  • Valuation risk - the company's reported price-to-earnings ratio near 65 suggests a high valuation that may expose the stock to downside if operational momentum slows.
  • Execution risk - achieving management's goal of growing results in fiscal 2027 through synergies, cost savings, and marketing depends on successful implementation of those initiatives.
  • Market sensitivity - while management projects growth independent of new housing or repair-and-remodel trends, continued weakness in those end markets could still affect volumes, particularly in siding.

Truist described the quarter as "another step towards rebuilding credibility" for James Hardie. The firm also noted that demonstrating the ability to deliver growth regardless of macroeconomic conditions would be pivotal to turning the stock into a relative outperformer within its group. Analysts' upward revisions to earnings estimates and the stronger-than-expected financials support an improving narrative, but the elevated valuation and the company's reliance on operational execution remain points to watch for investors and market participants focused on building materials, construction markets, and related industrial sectors.

Risks

  • High valuation - a P/E ratio near 65 may increase downside risk if operational momentum weakens.
  • Execution risk - achieving planned synergies, cost savings, and marketing-driven growth requires successful implementation.
  • Market sensitivity - siding and other volumes could still be pressured by broader housing or R&R market trends despite management's guidance.

More from Analyst Ratings

HSBC Lowers Synopsys Rating to Hold, Flags 2026 as Transition Year Feb 21, 2026 DA Davidson Cuts Uber Price Target Citing Elevated Investment; Buy Rating Intact Feb 20, 2026 Freedom Capital Markets Raises Freeport-McMoRan to Buy, Cites Copper Supply Tightness Feb 20, 2026 BofA Lifts CF Industries Price Target After Strong Q4 EBITDA; Maintains Underperform Rating Feb 20, 2026 Truist Lifts Tandem Diabetes Price Target as Company Shifts Toward Pharmacy Model Feb 20, 2026